Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brachytherapy | 8 | 2010 | 79 | 1.550 |
Why?
|
| Breast Neoplasms | 10 | 2015 | 1533 | 1.260 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2010 | 61 | 0.710 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2010 | 32 | 0.540 |
Why?
|
| Quality of Health Care | 1 | 2015 | 322 | 0.430 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 378 | 0.430 |
Why?
|
| Tissue Expansion Devices | 1 | 2011 | 2 | 0.430 |
Why?
|
| Mammaplasty | 1 | 2011 | 41 | 0.410 |
Why?
|
| Catheterization | 2 | 2009 | 209 | 0.390 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 445 | 0.380 |
Why?
|
| Lymph Nodes | 1 | 2011 | 258 | 0.380 |
Why?
|
| Sarcoma | 1 | 2010 | 70 | 0.360 |
Why?
|
| Radiodermatitis | 2 | 2006 | 8 | 0.360 |
Why?
|
| Consensus | 1 | 2010 | 211 | 0.360 |
Why?
|
| Mastectomy, Segmental | 5 | 2010 | 63 | 0.350 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 201 | 0.330 |
Why?
|
| Lung | 1 | 2011 | 849 | 0.290 |
Why?
|
| Carcinoma, Lobular | 1 | 2005 | 20 | 0.260 |
Why?
|
| Carcinoma in Situ | 1 | 2005 | 45 | 0.250 |
Why?
|
| Fanconi Anemia | 1 | 2004 | 7 | 0.250 |
Why?
|
| Vulvar Neoplasms | 1 | 2004 | 21 | 0.250 |
Why?
|
| Radiotherapy, Conformal | 1 | 2004 | 24 | 0.250 |
Why?
|
| Aged, 80 and over | 7 | 2015 | 4843 | 0.220 |
Why?
|
| Aged | 10 | 2015 | 14842 | 0.220 |
Why?
|
| Middle Aged | 11 | 2015 | 21119 | 0.200 |
Why?
|
| Adult | 10 | 2015 | 21375 | 0.190 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2010 | 125 | 0.180 |
Why?
|
| Radiotherapy Dosage | 3 | 2010 | 125 | 0.170 |
Why?
|
| Female | 13 | 2015 | 38015 | 0.170 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2010 | 129 | 0.170 |
Why?
|
| Survival Analysis | 2 | 2010 | 714 | 0.160 |
Why?
|
| Iridium Radioisotopes | 3 | 2007 | 11 | 0.150 |
Why?
|
| Models, Organizational | 1 | 2015 | 97 | 0.130 |
Why?
|
| Humans | 13 | 2015 | 68525 | 0.120 |
Why?
|
| Radiation Injuries | 2 | 2005 | 97 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2015 | 311 | 0.110 |
Why?
|
| Lymphatic Irradiation | 1 | 2011 | 3 | 0.110 |
Why?
|
| Mastectomy | 1 | 2011 | 56 | 0.100 |
Why?
|
| Time Factors | 3 | 2010 | 4655 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2015 | 413 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 799 | 0.100 |
Why?
|
| Radiation Oncology | 1 | 2010 | 12 | 0.100 |
Why?
|
| Axilla | 1 | 2010 | 36 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2010 | 86 | 0.090 |
Why?
|
| Lymph Node Excision | 1 | 2010 | 91 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2010 | 216 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 274 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2010 | 150 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2011 | 419 | 0.090 |
Why?
|
| Seroma | 1 | 2008 | 3 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 349 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1039 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 444 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 467 | 0.080 |
Why?
|
| Age Factors | 1 | 2010 | 1860 | 0.070 |
Why?
|
| Thoracic Wall | 1 | 2005 | 20 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2009 | 3702 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2005 | 132 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2010 | 2004 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 951 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 3256 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2005 | 84 | 0.030 |
Why?
|
| Male | 2 | 2010 | 37281 | 0.030 |
Why?
|
| Camptothecin | 1 | 2010 | 39 | 0.020 |
Why?
|
| Esophagitis | 1 | 2010 | 45 | 0.020 |
Why?
|
| Neutropenia | 1 | 2010 | 72 | 0.020 |
Why?
|
| Cisplatin | 1 | 2010 | 192 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 1055 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 475 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 168 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2010 | 7028 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 624 | 0.020 |
Why?
|
| Relative Biological Effectiveness | 1 | 2005 | 10 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 737 | 0.020 |
Why?
|
| Ribs | 1 | 2005 | 25 | 0.020 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2005 | 36 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2007 | 7264 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1851 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 5719 | 0.010 |
Why?
|